Kitov Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KTOV and buy or sell other stocks, ETFs, and their options commission-free!About KTOV
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The oncology pipeline includes CM24, NT219, and CAPTN-3.
CEOGil Efron, MBA, CPA
CEOGil Efron, MBA, CPA
Employees9
Employees9
HeadquartersRehovot, Tel Aviv
HeadquartersRehovot, Tel Aviv
Founded1968
Founded1968
Employees9
Employees9
KTOV Key Statistics
Market cap37.66M
Market cap37.66M
Price-Earnings ratio-0.73
Price-Earnings ratio-0.73
Dividend yield—
Dividend yield—
Average volume1.30M
Average volume1.30M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.20
52 Week high$5.20
52 Week low$0.5326
52 Week low$0.5326
Stock Snapshot
As of today, Kitov Pharmaceuticals(KTOV) shares are valued at $4.17. The company's market cap stands at 37.66M, with a P/E ratio of -0.73.
Kitov Pharmaceuticals(KTOV) stock opened on 2025-12-18 at —. The price climbed to — and dipped to —.
Kitov Pharmaceuticals(KTOV) shares are trading with a volume of 0, against a daily average of 1.3M.
In the last year, Kitov Pharmaceuticals(KTOV) shares hit a 52-week high of $5.20 and a 52-week low of $0.53.
In the last year, Kitov Pharmaceuticals(KTOV) shares hit a 52-week high of $5.20 and a 52-week low of $0.53.